Excess catecholamine syndrome. Pathophysiology and therapy

Annals of the New York Academy of Sciences

Volumn 881, Issue , 1999, Pages 430-444

  Rupp, Heinz ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CATECHOLAMINE; NORADRENALIN;

ADRENERGIC ACTIVITY; CALCIUM TRANSPORT; CALORIC INTAKE; CATECHOLAMINE URINE LEVEL; CONFERENCE PAPER; DIASTOLIC BLOOD PRESSURE; HEART RATE; HEREDITY; HYPERTENSION; INSULIN RESISTANCE; LIFESTYLE; MENTAL STRESS; PATHOPHYSIOLOGY; RESISTANCE BLOOD VESSEL; SARCOPLASMIC RETICULUM; SYSTOLIC BLOOD PRESSURE; TELEMETRY;

EID: 0032770214     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09391.x     Document Type: Conference Paper

References (98)

1. Heseker, H., S. Hartmann, W. Kubler & R. Schneider. 1995. An epidemiologic study of food consumption habits in Germany. Metabolism 44: 10-13.
2. Melnik, T. A., S. J. Rhoades, K. R. Wales, C. Cowell & W. S. Wolfe. 1998. Overweight school children in New York City: Prevalence estimates and characteristics. Int. J. Obes. Relat. Metab. Disord. 22: 7-13.
3. Siegrist, J., D. Klein & K. H. Voigt. 1997. Linking sociological with physiological data: The model of effort-reward imbalance at work. Acta Physiol. Scand. Suppl. 640: 112-116.
4. Peter, R. & J. Siegrist. 1997. Chronic work stress, sickness absence, and hypertension in middle managers: General or specific sociological explanations? Soc. Sci. Med. 45: 1111-1120.
5. Siegrist, J., R. Peter, P. Cremer & D. Seidel. 1997. Chronic work stress is associated with atherogenic lipids and elevated fibrinogen in middle-aged men. J. Intern. Med. 242: 149-156.
6. Bosma, H., R. Peter & J. Siegrist. 1998. Two alternative job stress models and the risk of coronary heart disease. Am. J. Public Health 88: 68-74.
7. Rupp, H. 1992. Insulin resistance, hyperinsulinemia, and cardiovascular disease. The need for novel dietary prevention strategies [editorial]. Basic Res. Cardiol. 87: 99-105.
8. Rupp, H. & R. Jacob. 1995. Excess catecholamines and the metabolic syndrome: Should central imidazoline receptors be a therapeutic target? Med. Hypotheses 44: 217-225.
9. Rupp, H. 1996. Nutritional disorders: A target for sympathetic outflow-regulating drugs (imidazoline I1 receptor agonists). Cardiovasc. Drugs Ther. 10: 213-214.
10. Scherrer, U., D. Randin, L. Tappy, P. Vollenweider, E. Jequier & P. Nicod. 1994. Body fat and sympathetic nerve activity in healthy subjects. Circulation 89: 2634-2640.
11. Troisi, R. J., S. T. Weiss, D. R. Parker, D. Sparrow, J. B. Young & L. Landsberg. 1991. Relation of obesity and diet to sympathetic nervous system activity. Hypertension 17: 669-677.
12. Landsberg, L. 1994. Pathophysiology of obesity-related hypertension: Role of insulin and the sympathetic nervous system. J. Cardiovasc. Pharmacol. 23: S1-8.
13. Young, J. B. & L. Landsberg. 1977. Suppression of sympathetic nervous system during fasting. Science 196: 1473-1475.
14. Hilderman, T., K. McKnight, K. S. Dhalla, H. Rupp & N. S. Dhalla. 1996. Effects of long-term dietary restriction on cardiovascular function and plasma catecholamines in the rat. Cardiovasc. Drugs Ther. 10: 247-250.
15. McKnight, K. A., H. Rupp, R. E. Beamish & N. S. Dhalla. 1996. Modification of catecholamine-induced changes in heart function by food restriction in rats. Cardiovasc. Drugs Ther. 10: 239-246.
16. Ernsberger, P., R. J. Koletsky, J. S. Baskin & L. A. Collins. 1996. Consequences of weight cycling in obese spontaneously hypertensive rats. Am. J. Physiol. 270: R864-72.
17. Haynes, W. G., D. A. Morgan, S. A. Walsh, W. I. Sivitz & A. L. Mark. 1998. Cardiovascular consequences of obesity: Role of leptin. Clin. Exp. Pharmacol. Physiol. 25: 65-69.
18. Van Duk, G., J. C. Donahey, T. E. Thiele, A. J. Scheurink, A. B. Steffens, C. W. Wilkinson, R. Tenenbaum, L. A. Campfield, P. Burn, R. J. Seeley & S. C. Woods. 1997. Central leptin stimulates corticosterone secretion at the onset of the dark phase. Diabetes 46: 1911-1914.
19. Scheurink, A. J. & A. B. Steffens. 1990. Central and peripheral control of sympathoadrenal activity and energy metabolism in rats. Physiol. Behav. 48: 909-920.
20. Tonino, R. P., K. L. Minaker, J. B. Young, L. Landsberg & J. W. Rowe. 1986. Splanchnic factors enhance the norepinephrine response to oral glucose in aged man. Exp. Gerontol. 21: 413-422.
21. Bourjeili, N., M. Turner, J. Stinner & D. Ely. 1995. Sympathetic nervous system influences salt appetite in four strains of rats. Physiol. Behav. 58: 437-443.
22. Stamler, J. 1997. The INTERSALT Study: Background, methods, findings, and implications. Am. J. Clin. Nutr. 65: 626S-642S.
23. Huang, B. S., S. J. Veerasingham & F. H. Leenen. 1998. Brain "ouabain," ANG II, and sympathoexcitation by chronic central sodium loading in rats. Am. J. Physiol. 274: H1269-H1276.
24. Pawloski-Dahm, C. M. & F. J. Gordon. 1993. Increased dietary salt sensitizes vasomotor neurons of the rostral ventrolateral medulla. Hypertension 22: 929-933.
25. Siegrist, J. 1996. Adverse health effects of high-effort/low-reward conditions. J. Occup. Health Psychol. 1: 27-41.
26. Rupp, H. 1989. Differential effect of physical exercise routines on ventricular myosin and peripheral catecholamine stores in normotensive and spontaneously hypertensive rats. Circ. Res. 65: 370-377.
27. Hansen, M. & H. Rupp. 1991. Cellular and molecular changes in the heart during stress or exercise. Methods Achiev. Exp. Pathol. 15: 58-83.
28. Patel, C., M. G. Marmot, D. J. Terry, M. Carruthers, B. Hunt & M. Patel. 1985. Trial of relaxation in reducing coronary risk: Four year follow up. Br. Med. J. (Clin. Res. Ed). 290: 1103-1106.
29. Van Montfrans, G. A., J. M. Karemaker, W. Wieling & A. J. Dunning. 1990. Relaxation therapy and continuous ambulatory blood pressure in mild hypertension: A controlled study. Br. Med. J. 300: 1368-1372.
30. Henry, J. P. 1997. Psychological and physiological responses to stress: The right hemisphere and the hypothalamo-pituitary-adrenal axis, an inquiry into problems of human bonding. Acta Physiol. Scand. Suppl. 640: 10-25.
31. Falk, J. L., M. Tang & S. Forman. 1977. Schedule-induced chronic hypertension. Psychosom. Med. 39: 252-263.
32. Rupp, H., B. Maisch & C. G. Brilla. 1997. Schedule-induced psychological stress and molecular structures of cardiomyocytes. Am. J. Physiol. 272: R776-82.
33. Rousseau, D., D. Moreau, D. Raederstorff, J. P. Sergiel, H. Rupp, R. Muggli & A. Grynberg. 1998. Is a dietary n-3 fatty acid supplement able to influence the cardiac effect of the psychological stress? [In Process Citation]. Mol. Cell Biochem. 178: 353-366.
34. Lin, Q. & P. Li. 1990. Rostral medullary cholinergic mechanisms and chronic stress- induced hypertension. J. Auton. Nerv. Syst. 31: 211-217.
35. Frankenhaeuser, M., U. Lundberg & L. Forsman. 1980. Dissociation between sympathetic-adrenal and pituitary-adrenal responses to an achievement situation characterized by high controllability: Comparison between type A and type B males and females. Biol. Psychol. 10: 79-91.
36. Ursin, H. & M. Olff. 1993. Psychobiology of coping and defence strategics. Neuropsychobiology 28: 66-71.
37. Saxena, P. R. 1992. Interaction between the renin-angiotensin-aldosterone and sympathetic nervous systems. J. Cardiovasc. Pharmacol. 19: S80-S88.
38. Rivier, C., T. Imaki & W. Vale. 1990. Prolonged exposure to alcohol: Effect on CRF mRNA levels, and CRF- and stress-induced ACTH secretion in the rat. Brain Res. 520: 1-5.
39. Kurosawa, M., A. Sato, R. S. Swenson & Y. Takahashi. 1986. Sympatho-adrenal medullary functions in response to intracerebroventricularly injected corticotropin- releasing factor in anesthetized rats. Brain Res. 367: 250-257.
40. Randin, D., P. Vollenweider, L. Tappy, E. Jequier, P. Nicod & U. Scherrer. 1995. Suppression of alcohol-induced hypertension by dexamethasone [see comments]. N. Engl. J. Med. 332: 1733-1737.
41. Puddey, I. B., L. J. Beilin, R. Vandongen, I. L. Rouse & P. Rogers. 1985. Evidence for a direct effect of alcohol consumption on blood pressure in normotensive men. A randomized controlled trial. Hypertension 7: 707-713.
42. Russ, R., A. R. Abdel-Rahman & W. R. Wooles. 1991. Role of the sympathetic nervous system in ethanol-induced hypertension in rats. Alcohol 8: 301-307.
43. Mao, L. & A. A. Abdel-Rahman. 1995. Blockade of L-glutamate receptors in the rostral ventrolateral medulla contributes to ethanol-evoked impairment of baroreflexes in conscious rats. Brain Res. Bull. 37: 513-521.
44. Palmer, A. J., A. E. Fletcher, C. J. Bulpitt, D. G. Beevers, E. C. Coles, J. G. Ledingham, J. C. Petrie, J. Webster & C. T. Dollery. 1995. Alcohol intake and cardiovascular mortality in hypertensive patients: Report from the Department of Health Hypertension Care Computing Project. J. Hypertens. 13: 957-964.
45. Moreira, L. B., F. D. Fuchs, R. S. Moraes, M. Bredemeier & B. B. Duncan. 1998. Alcohol intake and blood pressure: The importance of time elapsed since last drink. J. Hypertens. 16: 175-180.
46. Julius, S., A. V. Pascual, R. Sannerstedt & C. Mitchell. 1971. Relationship between cardiac output and peripheral resistance in borderline hypertension. Circulation 43: 382-390.
47. Messerli, F. H., J. G. De Carvalho, B. Christie & E. D. Frohlich. 1978. Systemic and regional hemodynamics in low, normal and high cardiac output borderline hypertension. Circulation 58: 441-448.
48. Julius, S. 1988. Transition from high cardiac output to elevated vascular resistance in hypertension. Am. Heart J. 116: 600-606.
49. Folkow, B. 1995. Hypertensive structural changes in systemic precapillary resistance vessels: How important are they for in vivo haemodynamics? J. Hypertens. 13: 1546-1559.
50. Preuss, H. G. 1994. Interplay between sugar and salt on blood pressure in spontaneously hypertensive rats. Nephron 68: 385-387.
51. Mark, A. L. 1991. Sympathetic neural contribution to salt-induced hypertension in Dahl rats. Hypertension 17: 186-190.
52. Crofton, J. T., M. Ota & L. Share. 1993. Role of vasopressin, the renin-angiotensin system and sex in Dahl salt-sensitive hypertension. J. Hypertens. 11: 1031-1038.
53. Grogan, J. R. & M. S. Kochar. 1994. Alcohol and hypertension. Arch. Fam. Med. 3: 150-154.
54. Siegrist, J., R. Peter, W. Georg, P. Cremer & D. Seidel. 1991. Psychosocial and biobehavioral characteristics of hypertensive men with elevated atherogenic lipids. Atherosclerosis 86: 211-218.
55. Laragh, J. H. 1992. Role of renin secretion and kidney function in hypertension and attendant heart attack and stroke. Clin. Exp. Hypertens. [A] 14: 285-305.
56. Gavras, H., I. Gavras, H. R. Brunner & J. H. Laragh. 1977. Effect of a new beta- adrenergic blocker, 1-bunolol, on blood pressure and on the renin-aldosterone system. J. Clin. Pharmacol. 17: 350-357.
57. Brunner, H. R., J. H. Laragh, L. Baer, M. A. Newton, F. T. Goodwin, L. R. Krakoff, R. H. Bard & F. R. Buhler. 1972. Essential hypertension: Renin and aldosterone, heart attack and stroke. N. Engl. J. Med. 286: 441-449.
58. Alderman, M. H., S. Madhavan, W. L. Ooi, H. Cohen, J. E. Sealey & J. H. Laragh. 1991. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension [see comments]. N. Engl. J. Med. 324: 1098-1104.
59. Zayas, V. M., J. D. Blumenfeld, B. Bading, M. McDonald, G. D. James, Y. F. Lin, N. E. Sharrock, J. E. Sealey & J. H. Laragh. 1993. Adrenergic regulation of renin secretion and renal hemodynamics during deliberate hypotension in humans. Am. J. Physiol. 265: F686-F692.
60. Holmer, S. R., B. Kaissling, K. Putnik, M. Pfeifer, B. K. Kramer, G. A. Riegger &A. Kurtz. 1997. Beta-adrenergic stimulation of renin expression in vivo. J. Hypertens. 15: 1471-1479.
61. Vaz, M., G. Jennings, A. Turner, H. Cox, G. Lambert & M. Esler. 1997. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 96: 3423-3429.
62. Fink, G. D. 1997. Long-term sympatho-excitatory effect of angiotensin II: A mechanism of spontaneous and renovascular hypertension. Clin. Exp. Pharmacol. Physiol. 24: 91-95.
63. Szabo, B., L. Hedler, C. Schurr & K. Starke. 1990. Peripheral presynaptic facilitatory effect of angiotensin II on noradrenaline release in anesthetized rabbits. J. Cardiovasc. Pharmacol. 15: 968-975.
64. Brilla, C. G., G. Zhou, H. Rupp, B. Maisch & K. T. Weber. 1995. Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover. Am. J. Cardiol. 76: 8D-13D.
65. Weidmann, P., L. M. Boehlen & M. De Courten. 1993. Pathogenesis and treatment of hypertension associated with diabetes mellitus. Am. Heart J. 125: 1498-1513.
66. Anfossi, G. & M. Trovati. 1996. Role of catecholamines in platelet function: Pathophysiological and clinical significance. Eur. J. Clin. Invest. 26: 353-370.
67. Patterson, S. M., K. A. Matthews, M. T. Allen & J. F. Owens. 1995. Stress-induced hemoconcentration of blood cells and lipids in healthy women during acute psychological stress. Health Psychol. 14: 319-324.
68. Cohn, J. N. 1995. Plasma norepinephrine and mortality. Clin. Cardiol. 18: I9-I12.
69. Reaven, G. M., H. Lithell & L. Landsberg. 1996. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N. Engl. J. Med. 334: 374-381.
70. Groop, L. C., C. Saloranta, M. Shank, R. C. Bonadonna, E. Ferrannini & R. A. DeFronzo. 1991. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 72: 96-107.
71. Facchini, F. S., R. A. Stoohs & G. M. Reaven. 1996. Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate. Am. J. Hypertens. 9: 1013-1017.
72. Jamerson, K. A., S. Julius, T. Gudbrandsson, O. Andersson & D. O. Brant. 1993. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 21: 618-623.
73. Sechi, L. A., C. Catena, L. Zingaro, S. De Carli & E. Bartoli. 1997. Hypertension and abnormalities of carbohydrate metabolism possible role of the sympathetic nervous system. Am. J. Hypertens. 10: 678-682.
74. Keltikangas-Jarvinen, L., N. Ravaja, K. Raikkonen & H. Lyytinen. 1996. Insulin resistance syndrome and autonomically mediated physiological responses to experimentally induced mental stress in adolescent boys. Metabolism 45: 614-621.
75. Halter, J. B., J. C. Beard & D. Porte, Jr. 1984. Islet function and stress hyperglycemia: Plasma glucose and epinephrine interaction. Am. J. Physiol. 247: E47-52.
76. DeFronzo, R. A., R. C. Bonadonna & E. Ferrannini. 1992. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15: 318-368.
77. Julius, S., T. Gudbrandsson, K. Jamerson & O. Andersson. 1992. The interconnection between sympathetics, microcirculation, and insulin resistance in hypertension. Blood Press. 1: 9-19.
78. Suzuki, J., M. Gao, Z. Xie & T. Koyama. 1997. Effects of the beta 2-adrenergic agonist clenbuterol on capillary geometry in cardiac and skeletal muscles in young and middle- aged rats. Acta Physiol. Scand. 161: 317-326.
79. Zeman, R. J., R. Ludemann, T. G. Easton & J. D. Etlinger. 1988. Slow to fast alterations in skeletal muscle fibers caused by clenbuterol, a beta 2-receptor agonist. Am. J. Physiol. 254: E726-732.
80. Rupp, H., R. Wahl & M. Hansen. 1992. Influence of diet and carnitine palmitoyltransferase I inhibition on myosin and sarcoplasmic reticulum. J. Appl. Physiol. 72: 352-360.
81. Rupp, H., H. J. Berger, A. Pfeifer & K. Werdan. 1991. Effect of positive inotropic agents on myosin isozyme population and mechanical activity of cultured rat heart myocytes. Circ. Res. 68: 1164-1173.
82. Randle, P. J., D. A. Priestman, S. Mistry & A. Halsall. 1994. Mechanisms modifying glucose oxidation in diabetes mellitus. Diabetologia 37: S155-S161.
83. Han, X. X. & A. Bonen. 1998. Epinephrine translocates GLUT-4 but inhibits insulin- stimulated glucose transport in rat muscle. Am. J. Physiol. 274: E700-E707.
84. Bousquet, P., J. Feldman & J. Schwartz. 1984. Central cardiovascular effects of alpha adrenergic drugs: Differences between catecholamines and imidazolines. J. Pharmacol. Exp. Ther. 230: 232-236.
85. Ernsberger, P., M. P. Meeley, J. J. Mann & D. J. Reis. 1987. Clonidine binds to imidazole binding sites as well as alpha 2-adrenoceptors in the ventrolateral medulla. Eur. J. Pharmacol. 134: 1-13.
86. Molderings, G. J. & M. Göthert. 1998. Presynaptic imidazoline receptors mediate inhibition of noradrenaline release from sympathetic nerves in rat blood vessels. Fundam. Clin. Pharmacol. 12: 388-397.
87. Young, J. B. & L. Landsberg. 1997. Suppression of sympathetic nervous system during fasting. Obes. Res. 5: 646-649.
88. Saltin, B., J. Henriksson, E. Nygaard, P. Andersen & E. Jansson. 1977. Fiber types and metabolic potentials of skeletal muscles in sedentary man and endurance runners. Ann. N.Y. Acad. Sci. 301: 3-29.
89. Tonino, R. P. 1989. Effect of physical training on the insulin resistance of aging. Am. J. Physiol. 256: E352-E356.
90. Ernsberger, P., R. J. Koletsky, L. A. Collins & D. Bedol. 1996. Sympathetic Nervous system in salt-sensitive and obese hypertension: Amelioration of multiple abnormalities by a central sympatholytic agent. Cardiovasc. Drugs Ther. 10: 275-282.
91. Rosen, P., P. Ohly & H. Gleichmann. 1997. Experimental benefit of moxonidine on glucose metabolism and insulin secretion in the fructose-fed rat. J. Hypertens. Suppl. 15: S31-S38.
92. Henriksen, E. J., S. Jacob, D. L. Fogt, E. B. Youngblood & J. Godicke. 1997. Antihypertensive agent moxonidine enhances muscle glucose transport in insulin-resistant rats. Hypertension 30: 1560-1565.
93. Lithell, H. O. 1997. Considerations in the treatment of insulin resistance and related disorders with a new sympatholytic agent. J. Hypertens. Suppl. 15: S39-S42.
94. Ziegler, D., M. A. Haxhiu, E. C. Kaan, J. G. Papp & P. Ernsberger. 1996. Pharmacology of moxonidine, an I1-imidazoline receptor agonist. J. Cardiovasc. Pharmacol. 27: S26-S37.
95. Rupp, H., B. Maisch & C. G. Brilla. 1996. Drug withdrawal and rebound hypertension: Differential action of the central antihypertensive drugs moxonidine and clonidine. Cardiovasc. Drugs Ther. 10: 251-262.
96. Berman, S. B. & T. G. Hastings. 1997. Inhibition of glutamate transport in synaptosomes by dopamine oxidation and reactive oxygen species. J. Neurochem. 69: 1185-1195.
97. 2. Am. J. Physiol. 274: H416-H423.
98. Rupp, H., K. S. Dhalla & N. S. Dhalla. 1994. Mechanisms of cardiac cell damage due to catecholamines: Significance of drugs regulating central sympathetic outflow. J. Cardiovasc. Pharmacol. 24: S16-24.